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Abstract: 
 Tumor necrosis factor (TNF) receptor associated factor 2 (Traf2) is suspected to 
be involved in the anti-apoptotic pathways of the innate immune system in the zebrafish. 
The expression of three different forms of Traf2, 2a1, 2a2, and 2b, was knocked down in 
pairs using antisense morpholino oligonucleotides in zebrafish embryos. A rescue was 
attempted by knocking down a potential receptor for the Traf2 to pathway. After 
infection with snakehead rhabdovirus (SHRV), mortality was quantified and the 
apoptotic effects of each of the Traf2 genes was assessed. Cell death was quantified using 
the TUNEL technique. The findings indicated that at least two zebrafish Traf2 proteins 
were necessary for function. Increased mortality due to infection was not caused by an 
increased amount of virus in the Traf2 morphants or increased amount of apoptosis.   
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Introduction 
 We are inundated every day by viruses. Ranging from the common cold to 
sexually transmitted diseases, everyone may be impacted by a viral infection at some 
point in their lives. The general viral infection process occurs when the virus is 
endocytosed by the cell. Once the virus enters, the nucleic acid of the virus is released 
into the cell cytoplasm to utilize host cell proteins for replication. As a protective 
mechanism, host cell proteins such as Toll-like receptors, recognize the DNA or RNA of 
the virus as foreign to the host. This initiates a protein signaling cascade that ultimately 
results in the translocation of transcription factors into the nucleus to transcribe pro-
inflammatory cytokines. Production of pro-inflammatory cytokines is the cell’s way of 
defending against the viral infection.  
 The immune system is the body’s defense against pathogens of all kinds, like 
viruses. There are two major branches: the innate immune system and the adaptive 
immune system. The adaptive immune system takes up to ten days to develop an 
appropriate response, but is then more specific to the pathogen and has a memory of the 
pathogen. It is composed of specialized white blood cells known as B and T-cells. The 
innate immune system protects the body during those first seven to ten days. Without a 
vigorous innate immune response, the adaptive immune response will not be as strong. 
The innate immune system provides a general response and is composed of the skin, 
mucous membranes, and various phagocytic cells. Generalized cell receptors, known as 
Toll-like receptors (TLRs), are responsible for recognizing the invading pathogens and 
initiating protein cascades to help cells deal with the infection. TLRs 3, 7, 8, and 9 are 
involved in viral recognition. 
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 In mammalian systems, TLR3 uses a TICAM1 dependent pathway to initiate the 
protein cascades, while TLRs 7-9 use a MyD88 dependent pathway. Zebrafish do not 
possess a protein homolog to TICAM1, and thus can only use MyD88-dependent 
signaling through the TLRs. To find potential signaling partners for MyD88 in zebrafish, 
a pulldown assay was conducted using zebrafish MyD88 as bait (unpublished data from 
Charette et al). A potential signaling partner for MyD88 was found to be Traf2 in this 
pulldown. 
One of the adaptor proteins in the mammalian TLR3-TICAM1 dependent pathway in 
mammalian systems is Traf2, a member of the tumor necrosis factor receptor associated 
factor protein family. In mammalian systems, Traf2 does not associate with MyD88, but 
based on the previous findings in the Kim lab, we hypothesized that Traf2 may be 
associating with MyD88 in a unique interaction not seen in mammalian systems. If Traf2 
is interacting with MyD88 in zebrafish signaling pathways this would be a unique and 
novel interaction not seen in any mammalian systems. For my senior thesis project, I 
examined the potential role of Traf2 in the zebrafish immune system.
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Literature Review 
Zebrafish as a model organism 
 During the 1960s, Dr. George Streisinger developed a new model organism for 
studying human diseases: the zebrafish (35). Over the next half century, this new model 
organism exploded with possibilities for research. A quick summary of some of these 
major landmarks is summarized in Figure 1 (adapted from 18). These early years were 
Figure 1: Major developments in zebrafish research (18). 
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focused on genes and genetics, especially since transcription and translation mechanisms 
were just being deduced. Streisinger was at the forefront of the genetics work with 
phages, an interest that naturally led him to mutational analysis in vertebrates (18). 
Additionally, Steisinger was known as a fish hobbyist. Trials with a variety of tropical 
fishes left zebrafish as the prime candidate over other fish such as the medaka – with 
previously developed genetic experimentation – due to their prodigious breeding, 
external fertilization, and clear embryos (18). His work during the 70s and 80s produced 
haploid embryos and homozygous diploid clones, throwing zebrafish into the limelight 
(35). 
The zebrafish (Danio rerio) is a common aquarium fish and excellent model 
organism for molecular research. The externally fertilized embryos develop in optically 
clear shells. The large clutch size and short generation time allow larger studies than 
more conventional model organisms such as mice (8, 14). Embryogenesis is completed 
by 50 hours post fertilization (hpf). Four days post fertilization (dpf) the adaptive immune 
system begins developing and is fully functional four to six weeks after fertilization (8, 
46). The zebrafish genome is completely sequenced and many molecular tools such as 
morpholinos are readily available to manipulate the genome. Other molecular tools 
include zinc finger nucleases, highly homozygous strains of zebrafish, and transgenic fish 
(14, 46).  
Zebrafish are excellent models for studying the immune system, particularly 
innate immunity (35). A variety of pathogens and even some parasitic organisms such as 
dinoflagellates have been used to replicate infections in human systems and set zebrafish 
as a model for infectious disease (Table 1) (35, 55).  
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Table 1: Pathogens infecting zebrafish to model infectious diseases (35). 
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Snakehead Rhabdovirus 
 Snakehead rhabdovirus (SHRV) is in the virus family Rhabdoviridae. It is 
enveloped and contains a negative-sense RNA genome. Originally cultured from infected 
snakehead fish, SHRV is effective in inducing viral infections and in zebrafish induces a 
cytokine response (35, 40). SHRV replicates at temperatures between 24 and 30 
o
C, an 
ideal temperature since zebrafish are maintained at 28
 o
C. Phelan et al demonstrated an 
effective infection technique for embryos and adult fish alike using immersion in egg 
water and virus (40). Immersing embryos from 24 hours post fertilization (hpf) to 3 days 
post fertilization (dpf) in 10
6
 TCID50 SHRV/mL for 5 hours and then washing the fish 
induced 55% and 47% mortality, respectively (8). After initial immersion, the virus 
invaded and spread throughout the fish and induced interferon production, a characteristic 
of viral infection (8).  
Innate Immunity 
 The immune system is compromised of two major branches: innate immunity and 
adaptive immunity. The innate immune system provides a first line of defense against 
pathogens with a immediate, non-specific response (27). In contrast, adaptive immunity 
has a specific response and possesses memory. The memory of the adaptive immune 
system provides a stronger response the second time a host is exposed to the pathogen 
(27).  
The two branches are linked in many ways and complement each other’s function 
(27). Innate immunity, the focus of this study, recognizes broad classes of pathogens with 
receptors that interact with proteins on the pathogen’s surface. The toll-like receptors 
(TLRs) are a family of transmembrane proteins that function within the innate immune 
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system as pattern recognition receptors (PRRs) (2). The PRRs are responsible for 
recognizing the pathogen associated molecular patterns (PAMPs), which are ligand 
motifs present on the outside of a pathogen surface. PAMPs, such as LPS and 
peptidoglycan, are recognized in general by class by the PRR. The binding of PRR-
PAMP initiates the TLR signal transduction pathways involved in the elimination of the 
pathogens, as appropriate for the general class of antigen. Activation of TLRs leads to the 
activation of NF-κB and induction of cytokines and interferons (1, 45). The TLR 
pathways that lead to cytokine induction have been characterized in mammals, including 
humans (42); however, in lower vertebrates, such as zebrafish, the TLR signaling 
pathways have not yet been defined (42, 45). 
Toll-like receptors  
Toll-like receptors (TLRs) were originally discovered in Drosophila as a  
  
Figure 2: General structure of TLRs. A. Domains of general TLR. B. Phylogenetic tree of TLRs and 
the PAMPs recognized. C. Differences between specific TLRs (24). 
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mechanism to resist microbial infections and as an important protein in development (2, 
27). An extracellular leucine-rich repeat region (LRR) and an intracellular 
Toll/interleukin-1R homology (TIR) domain create the generalized TLR structure 
(Figures 2, 3) (24, 27). The LRR is made up of the repeating amino acid motif 
LxxLxLxxN  and are characterized by a horseshoe solenoid tertiary structure (Figure 3) 
and β sheets within the concave section of the horseshoe (9, 24). 
TLRs can homo- and heterodimerize with 
other TLR molecules (27).  Intracellular 
signaling takes place through adapter 
molecules, such as MyD88 and TICAM, 
that bind the TLR TIR domain via their 
own TIR domain (24).  
TLRs recognize a variety of 
PAMPs, from lipoproteins to viral RNA 
(2). TLR1, -2, -4, -5, and -6 are on the cell surface and recognize bacterial parasites, 
gram-positive and gram-negative bacteria, flagellated bacteria, and fungi. Embedded in 
intracellular vesicles, TLR3, -7, -8, and -9 recognize viral dsRNA and ssRNA in addition 
to certain bacterial DNA elements (Figure 4) (27). 
Figure 3: Structure of TLRs (27). 
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Figure 4: Distribution of TLRs throughout the cell and major PAMP recognized by each TLR (27). 
TLRs are involved in a wide variety of cell signaling. An overview of some of the 
pathways they participate in is shown in Figure 10 (44).  Though all the pathways are 
initiated by different signals, such as flagellin or 
dsRNA, ultimately, the end is the same: apoptosis 
or inflammatory and immune gene activation. 
Apoptosis versus Necrosis 
 Cellular death is a highly controlled and 
moderated process within cells. The condensing 
and breakage of DNA and the creation of apoptotic 
bodies characterize apoptosis, or programmed cell 
death, whereas Figure 5: The differences between 
necrosis and apoptosis (36). 
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necrosis is characterized by membrane blebbing and the dumping of cellular contents (17, 
36). The terms associated with and utilized in cellular death are listed in Table 3 and 
summarized with their major characteristics (17). Though not listed in the table, necrosis 
is often associated with tissue damage. Apoptosis and necrosis can be difficult to 
distinguish, especially since the same stimuli at different doses can induce both types of 
cell death (15). Table 2 summarizes some of the characteristics between apoptosis and 
necrosis (15). The major difference is the rupturing of the cell membrane during necrosis 
that eventually leads the loss of 
the cytoplasm. Inflammation is 
another key difference present 
in necrosis but not in apoptosis 
(15).  
Table 3: Terms and definitions associated with cellular death (17). 
 
Traf2 
Traf2 is a member of the Traf superfamily of proteins, all of which share certain 
protein structures (5). At the carboxy-terminus, the Traf proteins share a homologous 
region that is thought to mediate dimerization of the Traf molecules (5). In vivo studies of 
Table 2: Major differences between apoptosis and necrosis (15). 
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Traf2 and other Traf proteins such as Traf6 show oligomerizaton utilizing the common 
Traf domain (7). The common Really Interesting New Gene (RING) domain is found at 
the amino-terminus of the Traf proteins and functions in an unknown manner (5). 
Following the RING domain, Traf proteins contain four to five zinc fingers (32). Traf 
proteins are found in the cytoplasm of cells and are thus thought to be adaptor proteins 
that associate with a variety of receptors, such as TNFα and CD40 (5). These receptors 
often contain death domains, such as TNFR1 associated death domain (TRADD) (39). 
When interacting with these death domains, Traf proteins are involved in transmitting 
signals downstream, often while utilizing their E3 ubiquitin ligase activity. The signaling 
cascades Traf proteins are involved in terminate in NF-κB activation and often serve as 
protection from apoptosis (39).  
Traf2 has been studied extensively in mice. These studies indicate that within 
mice and other mammals, Traf2 exists as a single protein (54). Traf2 deficient mice are 
smaller and die earlier than their control counterparts and Traf3 deficient mice (54). The 
phenotype could be partially rescued with blocking of the TNF receptor (54). Shi et al 
looked at Traf2 in HeLa cells and found it to undergo rapid K63 polyubiquitination 
following TNF stimulation (43). This is a vital step allowing Traf2 to function as an E3 
ligase with Ubc13 as the E2 ligase, often in pathways involved in regulating apoptosis 
(43).  
Ubiquitination 
 Ubiquitination is known to play a role in controlling apoptosis and cellular protein 
trafficking (33). Reversible covalent modification of proteins usually takes place on Ser, 
Tyr, Thr, or Lys residues. Lys and Cys are the primary targets for ubiquitination. E1 
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ligases activate the ubiquitin molecule with ATP and a thioester link. E2 ligases carry 
ubiquitin to the E3 ligase for transfer to the 
targeted protein through another thioester 
linkage (Figure 6) (33). The major family of 
E2 proteins is known as the Ubc family, 
which have a catalytic core (20). The Cys 
residue that carries the activated ubiquitin 
can be found within the catalytic core. The 
absence of Cys constitutes the sub-family of 
noncanonical ubiquitin-conjugating enzyme 
variant (Uev). Ubc13 and Uev1 form a heterodimer. Selectivity for K63 polyubiquitin is 
achieved with this unique dimer of proteins (20).  
E3 ligases are a family of proteins responsible for catalyzing the addition of 
ubiquitin to target proteins, primarily at K48 and K63. The ubiquitin protein has multiple 
Lys residues, allowing polymerization of long chains (33). K48 polyubiquitination acts as 
a signal for proteasome degradation. The long K63 linked ubiquitin tails are thought to 
create a scaffold for proteins to regulate NF- B levels. Longer chains generate a more 
intense signal (33).  
Signaling Pathways 
i. CD40 Receptor linked Activation of RelB 
Figure 6: Action of E1, E2, and E3 ligases in 
ubiquitinating a substrate (33). 
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In the activation of RelB, a protein in the NF- B family of transcription factors,  
through the CD40 receptor, the E2 ligase Ubc13 heterodimerizes with Uev1 (33, 52). The 
E2 activity of Ubc13/Uev1 is specific for tumor necrosis factor (TNF) receptor-
associated factors 2 and 6 (Traf2 and Traf6) K63 polyubiquitination. Together, 
Ubc13/Uev1 and Traf2/Traf6 
polyubiquitination at K63 (52). Ubc13 
assembles in a first tier along with the 
E3 ligases Traf2 and Traf3 and cellular 
inhibitors of apoptosis proteins (cIAP-
1 and cIAP-2) (Figure 7, box B). In 
unstimulated cells, cIAP-1/cIAP-2 act 
to polyubiquitinate K48 on NF-κB 
inducing kinase (NIK) in a complex 
similar to the first tier of assembly in stimulated cells, but not attached to the CD40 
receptor (49). Activated NIK will initiate the rest of the cascade that allows for RelB 
activation and translocation to the nucleus. If stimulated, Traf2 acts to ubiqutinate cIAP-
1/cIAP-2 at K63, a modification which changes the K48 polyubiqutination specificity of 
cIAP-1/cIAP-2. K63 polyubiqutitin cIAP-1/cIAP-2 catalyzes K48 poly-ubquitin tails to 
be added to Traf3 (49). In the second step of complex assembly, the K63 
polyubiqutitinated Traf2 is thought to act as a scaffold for binding of MKK4 (a substrate 
for MEKK1), mitogen activated protein kinase (MAPK) protein MAP or extracellular 
signal-regulated kinase kinase 1 (MEKK1), and inhibitor of nuclear factor B (I B) 
kinase γ (IKKγ) (34). 
Figure 7: Assembly of proteins at CD40 receptor and 
translocation to the cytosol (34). 
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The completed protein complex is attached to the receptor though Traf3. 
Proteasome degradation of Traf3, due to K48 polyubiquitin, releases the complex into the 
cytosol (Figure 
8). The activated 
complex stops 
ubiquitinating 
NIK and instead 
phosphorylates 
NIK. 
Phosphorylated 
NIK is activated 
and 
phosphorylates IKKα (49). The phosphorylation of p100 occurs at S886 and S870. 
Degradation and processing are signaled by K48 polyubiquitin chain catalyzed by NIK 
(50). The degradation of p100 generates p52. RelB dimerizes with p52 and translocates to 
the nucleus to activate transcription (49).  
ii. Toll-like Receptor 3 Activation of NF-κB 
TLR3 is sequestered in the endosome and will recognize dsRNA (Figure 4) (28). 
Previous studies have shown it to be the only Toll-like receptor to operate independently 
of the MyD88-dependent pathway (28). After a virus has successfully infected a cell, the 
dsRNA is released and protein synthesis of viral proteins begins. Dimerized TLR3 can 
then bind the dsRNA imported into the endosome (3, 56). Binding of antigen to the 
Figure 8: Noncanonical activation of NF-κB family member RelB thorugh the 
CD40 receptor (49). 
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receptor recruits TIR domain-containing adaptor molecule 1 (TICAM1) to the 
cytoplasmic end of the TLR through the TIR domain on each of the proteins (38, 53, 56). 
Like other TLR adaptor proteins, TICAM1 (also known as TRIF) homodimerizes and is 
capable of signaling to 
activate Type 1 interferon or 
NF-κB (Figure 9) (28, 38). 
TICAM1 functions as a 
signaling platform, allowing 
a variety of proteins such as 
Traf3, Traf2, Traf6, NAP1 
and receptor interacting 
protein 1 (RIP1) to bind and 
relay signaling (3, 56). 
Signaling through RIP1 
activates NF-κB. RIP1 is auto-phosphorylated and polyubiquitinated by Peli1 or Traf2 at 
K63 and K48 (49, 56). This polyubiquitin chain serves as a scaffold for the assembly of 
Traf6, MAP3K, TAK1, and TAB2 (23, 56). The complex translocates to the cytoplasm 
and interacts with PKR which phosphorylates TAK1 (23, 56). TAK1 activates MAP 
kinase signaling cascades or activates IKK (56). The IKK complex phosphorylates IκB, 
allowing NF-κB to translocate to the cytoplasm and activate pro-inflammatory cytokines 
(49). RIP1 also activates caspase-8 through FADD and to promote apoptosis (56). 
 
Figure 9: Overview of pathways initiated by the TLRs (44). 
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iii. Toll-like Receptor 9  
TLR is localized to endosomes and recognizes viral and bacterial CpG DNA 
motifs found on microbial genomes (25). In unstimulated cells, TLR9 is sequestered in 
the endoplasmic reticulum, but after stimulation is quickly trafficked to the endosome 
and proteolytically cleaved (25). Proteolytic cleavage activates TLR9 and allows the 
receptor to bind ligand (25). Like most TLRs, TLR9 has a TIR domain to recruit the 
adaptor molecule myeloid differentiation factor 88 (MyD88) for signal transduction. 
Binding of the TIR domain of MyD88 to the TIR domain of TLR9 initiates the MyD88-
dependent pathway that activates NF-κB and the MAPK signaling cascades (11, 25). The 
MyD88 pathway is detailed in Figure 10. 
 MyD88 recruits Traf6, IRAK4, and sometimes IRAK1 and IRAK2 to assemble at 
TLR9 (25). Traf6, an E3 ubiquitin ligase, activates the TAK1/TAB1/TAB2/TAB3 
complex through K63 polyubiquitination, which in turn activates the classical MAPK 
signaling cascade or activates NF-κB (11). In the activation of NF-κB, the TAK1/TAB 
complex activates the IKK complex through phosphorylation (25). The phosphorylated 
IKK complex modifies the regulatory IκB molecules with a phosphate group, targeting 
IκB for destruction by the proteasome. Free NF-κB translocates into the nucleus and 
induces transcription of inflammatory cytokines (25).  
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Figure 5: MyD88-dependent signaling cascade to activate inflammatory cytokines (26). 
 
iv. TNFR1 Activation of NF-κB 
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Tumor necrosis factor receptor type 1 (TNFR1) is activated by the pro-
inflammatory cytokine tumor necrosis factor α (TNFα) (29). After stimulation, the 
receptor trimerizes 
and recruits the 
adaptor protein 
TNFR1-associated 
death domain 
protein (TRADD) 
to the cytoplasmic 
domain (49). 
Traf2, Traf5 and 
RIP1 are all 
recruited and 
assemble at TRADD (Figure 11) (16, 49). RIP1 is K63-linked polyubiquitinated and 
Traf2 is phosphorylated by protein kinase C (PKC) (30). Phosphorylated Traf2 is K63 
polyubiquitinated (30). It is thought that before phosphorylated Traf2 is 
polyubiquitinated, it recruits IKKα and IKKβ (the catalytic subunits of the IKK complex) 
(30). Polyubiquitination of Traf2 promotes recruitment of a TAB/transforming growth 
factor-β-activated kinase 1 (TAK1) complex to the receptor complex (30). TAK1 is K63 
polyubiquitinated by Traf2 (16). K63 polyubiquitinated TAK1 recruits the regulatory 
protein for the IKK complex, IKKγ/NEMO by providing a scaffold for binding (16). The 
completed IKK complex is then phosphorylated on the IKKβ subunit by TAK1 (16). 
Figure 11: TNFR1 signaling cascade and activation of NF-κB (16). 
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Activated IKK complex phosphorylates the IκB family members, leading to IκB 
degradation and release of NF-κB (49). 
Genetic manipulation of the zebrafish genome 
The ease of genetic manipulations in zebrafish is one of their major advantages. 
Multiple techniques have been developed to knockdown or knockout genes in zebrafish. 
Some of these techniques include: targeting induced local lesions in genome (TILLING), 
morpholino knockdowns, and transgenesis (35). 
 Mopholinos have a variety of mechanisms to block protein synthesis. The general 
structure of a morpholino is a twenty 
five morpholino base oligomer (10). 
These bind tightly and strongly to the 
RNA because of their 
phosphorodiamidate backbone 
(Figure 12, box A) (10). The two 
major forms of morpholinos are 
splice blockers (Figure 12, box B) 
and translational blockers (Figure 12, 
box E) (10). Splice blockers inhibit 
the formation of the splicesome 
complex and are usually used in zygotic embryos, whereas the translational blockers bind 
the untranslated region of the mRNA and are used in both maternal fish and zygotic fish.  
 
 
Figure 12: Different modes of action for morpholinos 
(10). 
20  
Preliminary proceedings to discover Traf2 
The ubiquity of viruses in day to day life presents many challenges in health care. 
The immune system is the body’s mechanism to not only protect itself against these 
invaders but to also clear infections that have taken hold. The innate immune system, 
composed of generalized defense mechanisms such as skin and phagocytes, works to 
clear infections during the first seven to ten days and is critical to mounting a strong 
adaptive immune response. Pattern recognition receptors known as Toll-like receptors 
(TLRs) are major players in recognizing the viral infection and relaying this information 
into the cell.  
Previous data suggest that unique signaling partners may exist in zebrafish TLR 
pathways. Sullivan et al. reported several protein-protein interactions observed in the 
mammalian TICAM1-dependent pathway are not observed in zebrafish (47). Yet the 
zebrafish TICAM1-dependent pathway was capable of eliciting a similar cytokine profile 
for Type I IFN and NF-κB activation. Due to several known mammalian protein-protein 
interactions not occurring in zebrafish we hypothesized that unique protein partners must 
be signaling. To identify possible 
unique protein interactions a protein 
pulldown assay using MyD88 as bait 
was conducted. Charette et al 
(unpublished) demonstrated a unique 
interaction between zebrafish Traf2 
and MyD88 (Figure 13). 
All three of the Traf2 paralogs 
Figure 13: Each of the three paralogs of Traf2 is 
shown to associate with MyD88. 
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interacted with MyD88, as seen in lanes 1-3. The purpose of this study was to look at the 
potential roles for Traf2 in zebrafish signaling, particularly during a viral infection. 
Materials and Methods  
Zebrafish maintenance 
Zebrafish embryos of the wild-type AB strain were maintained in petri dishes 
containing no more than two hundred embryos in 60 mL of egg water (60 mg/L Instant 
Ocean, Spectrum Brands, Madison, WI). For 6 h post fertilization, egg water was 
supplemented with 20 μL 0.1% methylene blue to help prevent fungal growth and 
bacterial infections. After immersion in methylene blue, embryos were split into plates 
containing two hundred embryos. Embryos were maintained in a 28 
o
C incubator and egg 
water was changed daily. Maintenance was modified from Phelan et al (40). 
Morpholino knockdown 
Morpholino injections were performed according to Bill et al with some 
modifications (10). Antisense morpholino oligonucleotides (MO) were designed by 
GeneTools (Philomath, OR) for each paralog of Traf2 to block splicing (Table 4). Within 
1 hpf, embryos yolks were injected with 2 nL MO of each of the appropriate morpholinos 
using an MPPI-2 pressure injection system (Applied Scientific Instrumentation, Eugene, 
OR). After injection, embryos were immersed in 20 μL 0.1% methylene blue in 60 mL 
egg water for 5 h. 
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Table 4: Morpholinos used in this experiment. 
Name Sequence MW Mol. 
Abs. 
Weight OD 
TNFR1v1 
constant 
34 
TACGTCCTTGTGCATTGCTGGCATC 8417 249090 2.53 74.73 
TNFR1v2 
constant 
33 
CTGCATTGTGACTTACTTATCGCAC 8385 254250 2.52 76.27 
Traf2a1 
E1/I1 
CAGGACTGAATGCCGCTTACCTCAC 8389 255430 2.52 16.63 
Traf2A2 
E1/I1 
AGATCAGCGGTGTGAATTACCCAAC 8477 264190 2.54 79.26 
Traf2b 
E1/I1 
TTTAAGAATCAAGGCTTACCACTGC 8427 263690 2.53 79.11 
 
Immersion infections 
At 3 dpf, one hundred embryos per treatment of morpholino knockdowns (the 
triple knockdown of all three Traf2 genes, control morpholino) added to small petri 
dishes. A concentration of 1 x 10
6
 TCID50 SHRV per mL
-1
 was added to the fish. After 
incubation for 5 h, the embryos were washed 3 times in 60 mL of clean egg water. On a 
daily basis for 5 days, egg water was changed and zebrafish were monitored for 
mortalities. This procedure was modified from Phelan et al (40). 
Viral burden studies 
Ten fish were collected and homogenized in media every 24 h. Viral burden was 
determined by serially diluting the filtered homogenate in EPC cells (40). After 48 h cells 
were examined for death. This procedure was adapted from Phelan et al (40).  
TUNEL Assay 
Ten fish were collected for each TUNEL timepoint and incubated overnight at 4 
o
C in 500 μL of 4% para-formaldehyde (PFA) in a 1.5 mL microcentrifuge tube. Fish 
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were immersed once for 5 min in 33% MeOH in PBS and 66% MeOH in PBS, and 
immersed twice in  100% MeOH for 5 min. The permeablized fish were then stored at 
−20oC. This procedure was adapted from Yabu et al (51). 
The TUNEL assay itself was adapted from Invitrogen (21). Individual fish were 
transferred to 1.5 mL microcentrifuge tubes and treated with 5-min washes in 66% 
MeOH in PBS, and 33% MeOH in PBS, followed by 2 5-min washes in (51). Fish were 
equilibrated in TdT buffer for 10 min (21). After 2 h at 37
o
C in the TdT reaction cocktail 
(21),  the fish were washed twice for 20 min  in 1x Western Blocking buffer in TBS 
(Roche 1921673 Brandford, CT) (12, 21). Finally, fish were treated for 30 min at room 
temperature in the dark with Click-iT reaction cocktail (Invitrogen) before an overnight 
incubation at 4 
o
C in 1x Western Blocking buffer in TBS (21).  
Ubiquitin Assay 
 293T cells at 90 – 95% confluency were transfected with one of the Traf2 
paralogs tagged with hemagluttin (HA), RIP1 tagged with myc, and wild type ubiquitin 
plasmid tagged with HA using Lipofectamine 2000 according to the manufacturer’s 
recommendations (Addgene #17608). At 6 h post transfection (hpt), media was replaced 
with 100 nM sphingosine 1-phosphate. At 48 hpt, the cells were washed with phosphate 
buffered solution(PBS) (Invitrogen Life Technologies) and lysed in buffer containing 50 
mM Tris-HCl at a pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and a protease 
inhibitor (Sigma-Aldrich) (48). After centrifugation at 16,000 x g for 15 min, the cleared 
cell lysate was incubated overnight at 4 
o
C with anti-HA agarose affinity gel resin or anti-
myc agarose affinity gel resin (Sigma-Aldrich, St. Louis, MO). The whole cell lysate and 
immunoprecipitate were washed 3 times in buffer containing 25 mM Tris-HCl (pH 7.2), 
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150 mM NaCl, and 0.05% Tween 20 (48). The immunoprecipitates were eluted in 2x 
lane marker nonreducing sample buffer for 5 min at 100 
o
C (Pierce Rockford, IL) and 
separated on a SDS-PAGE gel (48). The separated proteins were transferred onto 
nitrocellulose overnight at 4 
o
C. Membranes were blocked with TBS (pH 7.5) with 0.1% 
Tween 20 and 5% nonfat dried milk before treating with mouse monoclonal primary 
antibody against the myc tag at 1:500 for 2 h at room temperature (Santa Cruz 
Biotechnology) and a secondary anti-mouse antibody linked to HRP for imaging at 
1:50,000 overnight at 4 
o
C (Amersham Biosciences). Polyclonal rabbit anti-HA, at 1:250 
was incubated for 2 h at room temperature for the other immunoprecipitate (Thermo 
Scientific) and the secondary goat anti-rabbit monoclonal IgG linked to horse radish 
peroxidase (HRP) for imaging at 1:50,000 was incubated overnight at 4 
o
C (Santa Cruz 
Biotechnology). This procedure was adapted from Sullivan et al (48).  
Confocal microscopy 
Images were analyzed with an Olympus IX-81 equipped with an Olympus FV-
1000 laser scanning confocal unit using the Olympus FV-10 software package.
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Results  
Traf2 knockdown fish exhibit greater mortality when infected with SHRV. 
 
Figure 14: Triple knockdown Traf2 fish experience greater mortality than control fish when infected 
with SHRV. Mean mortality in Traf2 triple knockdown fish challenged with SHRV as compared to control 
infected fish and uninfected fish. Error bars represent the standard error between the two replicates. 
Previous studies done by Yeh et al showed early lethality in Traf2 deficient mice 
and runting in the mice (54). We investigated whether zebrafish embryos showed the 
same runting and premature death. Zebrafish embryos were injected with the three Traf2 
morpholinos at once (Table 4) at the one to two cell stages. At 3 dpf the embryos were 
immersed in 1 x 10
6
 TCID50/ml SHRV for 6 h. Survival was monitored over the next 5 
days. Higher levels of mortalities were observed in Traf2 triple knockdown challenenged 
with SHRV compared to control zebrafish (Figure 14). These results indicated the during 
a virus infection of the zebrafish, knockdown of the three Traf2 paralogs leads to greater 
mortality. 
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Figure 15: Pairwise knockdown Traf2 fish experience greater levels of mortality when infected with 
SHRV than control fish. Mean mortality levels in Traf2 pairwise knockdown fish after SHRV challenge. 
Error bars represent the standard error between the two replicates. 
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We wanted to investigate whether the increased mortality seen in Traf2 tri-
morphants was due to the combined action of all three paralogs or if two served 
redundant and protective roles. To investigate this question, we knocked down all three 
pairs of Traf2 morpholinos and the individual Traf2 morpholinos (Table 3). The pairwise 
knockdowns of the Traf2 paralogs showed an increase in mortality over the control 
zebrafish as well (Figure 15). However, the single knockdowns of Traf2 paralogs did not 
show an increase in mortality compared to the control zebrafish (Figure 16). 
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Figure 16: Knockdown of the individual Traf2 genes in fish infected with SHRV does not increase 
mortality as compared to control fish. Mean mortality of individual Traf2 knockdown fish challenged 
with SHRV as compared to control fish. Error bars represent standard error between two replicates. 
The results indicate that Traf2 pairwise morphants are more susceptible to death during a 
viral infection, but that individual Traf2 genes are not sufficient to cause this increase in 
mortality during viral infection. 
Traf2 zebrafish and control fish have no difference in viral burden  
 An increase in mortality during a viral infection is often the result of a high viral 
burden. To determine if this was the case in our scenario, the fish were sampled for viral 
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burden every 24 h for 3 days. 
 
Figure 17: Traf2 tri-morphants do not have a greater viral burden than control fish. Mean viral 
burden in SHRV challenged tri-morphant Traf2 zebrafish. 
There was no significant difference in viral burden between the triple Traf2 knockdown 
fish and the control fish (Figure 17). This indicates that although Traf2 morphants exhibit 
a higher mortality during viral infection, the increase in mortality is not due to an 
increaed amount of virus infecting the fish. 
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TNFR1 knockdown does not improve mortality seen with Traf2 knockdowns 
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Figure 18: Eliminating the receptor TNFR1 does not increase survival in Traf2 triple knockdown 
fish. Mean mortality of Traf2/TNFR1 morphants as compared to controls. Error bars represent standard 
error between two replicates. 
To determine the possible pathways that Traf2 is involved in, the TNFR1 receptor 
was knocked down alone or with the three Traf2 paralogs. It has been shown that Traf2 
has a protective role in the TNFR1 pathway (37). By removing the receptor, there was an 
increase in survival of the mice in the study done by Nguyen et al (37). Few fish survived 
until the third day for infection with SHRV, so the fish mortality while uninfected was 
monitored from 24 hpf on until 120 hpf. We did not, however, see an increase in survival 
when we knockdown Traf2 with TNFR1 (Figure 18). Bates et al were able to use the 
TNFR1 morpholinos with success in their own experiments, though they were not using 
the morpholinos in conjugation with the Traf2 morpholinos (6). Thus the lack of rescue 
in the zebrafish when using the TNFR1/Traf2 tri-morphants may be because the zebrafish 
Traf2 proteins are not as intimately involved in the TNFR1 signaling pathway as mouse 
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Traf2 is in the mouse TNFR1 pathway. The results from this experiment do not show an 
increase in survival in Traf2 tri-morphants that are also deficient in TNFR1.  
Traf2 may increase apoptosis, which may lead to increased mortality 
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Figure 19: Triple knockdown Traf2 fish infected with SHRV experience greater levels of apoptosis 
than control infected fish. Mean number of cells undergoing apoptosis in Traf2 tri-morphants challenged 
with SHRV. Error bars represent standard error between the three fish sampled. 
Previous studies have indicated that Traf2 negatively regulates apoptosis through 
the Caspase-8 pathway (19). To look at the possible role of Traf2 in preventing apoptosis 
in the zebrafish, we analyzed SHRV infected fish at 1 – 4  dpi via the TUNEL assay. The 
TUNEL assay attaches a fluorescent probe to the nicked ends of DNA. A characteristic 
feature of cells undergoing apoptosis is DNA fragmentation, a process that leaves lots of 
ends of DNA open for TUNEL staining (36). TUNEL stained fish were analyzed by 
confocal microscopy. Cells undergoing apoptosis were counted in each fish, though 
results were inconsistent.  In general there were more apoptosic cells in the Traf2 
knockdown fish than in the controls, however the difference in number of apoptotic cells 
was not statistically significant (Figure 19).  
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Traf2 as E3 ubiquitin ligase 
In mammalian systems, Traf2 acts as an E3 ubiquitin ligase, ubiquitinating cIAP-
1/cIAP-2 at K63 (49). To investigate whether the three Traf2 paralogs in zebrafish could 
function as an E3 ubiquitin ligase, 293T cells were transfected with plasmids containing 
the Traf2 paralogs, RIP1, and ubiquitin, (Figures 20 – 22) (31). The cells were lysed and 
immunoprecipitated for the myc tag. This targests RIP1, a potential target for E3 
ubiquitination by Traf2. A second experiment immunoprecipitated for the HA tag, 
targeting the ubiquitin molecules and the Traf2 paralogs. Traf2a2 is expressed by the 
transfected 293T cells, but the other two Traf2 paralogs are not. This may be due to poor 
expression of Traf2a1 and 2b and is a problem we are actively still investigating. Traf2a1 
and 2b could also be masked by high expression of ubiquitin. RIP1 expression was also 
observed in expressed transfected 293T cells (Figure 21). RIP1 did not produce smearing 
that is characteristic of polyubiquitinated proteins (Figure 20), leading us to believe that 
polyubiquitination is not occurring between the individual Traf2 paralogs and RIP1. RIP1 
is not being ubiquitinated in these cells as the immunoprecipitate for HA blotted for the 
myc tag yielded no product. 
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Figure 20: RIP1 is not ubiquitinated by Traf2. Immunoblot of cell lysate immunoprecipitated for the 
myc tag present on RIP1. The top box was blotted for the HA tag present on the Traf2 proteins and 
ubiquitin, while the bottom box was blotted for the myc tag.  
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Figure 21: Ubiquitin is most likely present in the cells. The top box is an immunoblot of cell lysate 
immunoprecipitated for the HA tag present on ubiquitin and the Traf2 proteins and blotted for the HA tag 
present on the Traf2 proteins and ubiquitin. The bottom box was blotted the whole cell lysate blotted for the 
myc tag. 
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Figure 22: Traf2a2 is the only Traf2 paralog to be expressed in the blot. Immunoblot of the whole cell 
lysate for the HA tag present on ubiquitin and the Traf2 proteins.
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Discussion 
 Traf2 is critical in regulating apoptosis in mammalian systems. It acts as an E3 
ligase to poly-ubiquitinate cIAP-1/cIAP-2 at K63 (34, 49). In mice, Traf2 deficiency 
caused runting and early death due either to TNF receptor lethality or increased apoptosis 
(54). In mammalian systems, Traf2 exists as a single protein involved in a variety of 
pathways, including TLR3, TNFR1, and many others with death domains (39). Zebrafish 
are unique and possess three Traf2 paralogs: Traf2a1, Traf2a2, and Traf2b. The potential 
for unique interactions with other proteins like MyD88 (Figure 13) makes research with 
the zebrafish Traf2 proteins vital to understanding the alternative pathways and 
mechanisms organisms use to protect against inflammation and apoptosis. 
Previous studies using mice as a model demonstrated that Traf2 deficiency leads 
to early mortality without infection (54). If zebrafish experience lethality in the same 
manner as mammalian 
systems, it will provide 
insight into the pathways 
that utilize the zebrafish 
Traf2 paralogs. The 
Traf2 tri-morphants 
infected with SHRV 
experiences greater 
levels of mortality than 
the control fish (Figure 
14). This may be due to Traf2 involvement in anti-apoptotic pathways, perhaps acting as  
Figure 23: TNFα signaling pathway to inflammatory cytokines or 
apoptosis (19). 
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mlevels of mortality in fish prior to infection that were between 24 and 72 hpf  were 
observed (Figure 18). In Figure 24 we can see that Traf2 works to inhibit apoptosis 
through the Caspase-8 pathway. By removing Traf2, there is potential for greater 
apoptosis without that level of regulation. Apoptosis will occur because Traf2, which is a 
negative regulator of the Caspase-8-dependent pathway, has been removed, allowing the 
pathway to proceed. Greater levels of apoptosis could cause an increase in mortality. 
Mice deficient in Traf2 showed early lethality and runting, similar to the effects seen in 
the zebrafish (54). Yeh et al determined that this early mortality was not just due to Traf2 
playing a role in TNFR signaling, but that Traf2 must also be vital in other signaling 
pathways such as TLR3 signaling and signaling through the CD40 receptor (54). These 
findings are consistent with our findings in the zebrafish. The pairwise knockdown fish 
experience similar levels of mortality rates to each other, from 50 – 70 % survival (Figure 
15), suggesting that at least two of the paralogs of Traf2 are required for function. When 
paired with the results of the single Traf2 morphants where no increase in mortality is 
observed (Figure 16), this suggests that zebrafish Traf2 may be forming heterodimers or 
even heterotrimers, a result consistent with previous studies have shown demonstrating 
that mammalian Traf2 homodimerize (43). 
The increase in mortality observed in virus infected Traf2 morphants may be due 
to the inability to clear the virus. The viral burden was assessed in both Traf2 tri-
morphants and control fish and there was no significant difference in viral burden (Figure 
17). Therefore, the increase in mortality is not due to an increase in viral burden. Traf2 is 
not a key player in a pathway that clears virus.  
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Since viral burden is not the cause of the increase in mortality, we looked at the 
levels of apoptosis in the fish. In mammals, Traf2 is a negative regulator of apoptosis in 
Caspase-8 pathway (Figure 23). Utilizing the TUNEL assay to label apoptotic cells in 
vivo, SHRV infected Traf2 tri-morphants and control fish were compared over 4 days. A 
moderate increase in apoptotic cells in the Traf2 tri-morphants was observed (Figure 18), 
though these numbers varied widely between replicates. The greatest increase in 
apoptosis occurs between two and three days post infection. The apoptosis seen in the 
fish was localized mostly along the fin of the tail and could be due to developmental 
apoptosis or normal cell death on the skin edge. The Traf2 tri-morphants did have some 
apoptosis in the eye region; this was not significantly different than the control fish. The 
slight increase in apoptosis in the Traf2 tri-morphants could also be caused by off-target 
effects of morpholinos, as not all morpholinos have the same effects on the developing 
embryos (10). It is entirely possible that the Traf2 morpholinos have the potential to 
cause more p53-induced apoptosis than the control morpholinos, particularly since we 
saw apoptosis in the eye region, which is characteristic of the off target effects (10). 
Reimers et al used the TUNEL assay in conjugation with an acridine orange stain to 
depict apoptosis in ethanol stressed zebrafish embryos (41). Acridine orange stains cells 
undergoing death in general, and does not allow differentiation between necrosis and 
apoptosis. For this reason, we chose to only use the TUNEL assay, which is specific for 
apoptosis through the tagging of nicked DNA. Reimers et al were able to show apoptosis 
in embryos of a similar age range, in much greater quantities than we were able to 
achieve (41). Reimers’ group may have been more successful in their numbers because 
they were not co-injecting with the Traf2 morpholinos or because they did not need as 
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great of numbers of zebrafish embryos to survive. For infection/mortality studies, we 
need a greater number of fish to survive until the third day post fertilization than for 
studies focusing just on mortality. Because results were inconsistent, we cannot 
definitively say that the increase in mortality is caused by the Traf2 knockdown, but it 
may be a contributing factor. 
Because simultaneous removal of the TNFR1 receptor with Traf2 rescues the 
effects in Traf2 deficient mice, the TNFR1 receptor was knocked down in the zebrafish 
(54). However, there was not a significant increase in survival of the Traf2 tri-morphants. 
In zebrafish, unlike mice, there are two TNFR1 receptor genes: TNFR1v1 and TNFR1v2. 
The TNFR1 morpholinos were originally described by Bates et al in zebrafish (6). The 
group showed TNFR1 deficient fish were more resistant to lipopolysaccharide exposure, 
a potent toxin (6). Simultaneous knockdown of TNFR1v1, TNFR1v2, Traf2a1, Traf2a2, 
and Traf2b resulted in no change in mortality as compared to the Traf2 tri-morphants 
(Figure 18). Knockdown of TNFR1v1 and TNFR1v2 may have rescued the Traf2 tri-
morphant high mortality phenotype but the high amount of morpholino that was injected 
per embryo may have caused off-target effects. Morpholinos have the potential to cause 
side effects such as enlarged eyes, swollen yolk sacks and early death (10). The lack of 
rescue in our studies may be because of a difference in the TNFR1 pathways of mice and 
zebrafish. Though Traf2 is involved in the mouse TNFR1 pathway, the zebrafish may use 
an alternative method of signaling. Incomplete rescue of the Traf2 tri-morphants may 
also be due to cross-talk amongst different pathways. For instance, in mammalian 
systems both TLR3 and TNFR1 utilize RIP1 in downstream cascades (13). RIP1 is 
polyubiquitinated and eventually leads to NF-κB activation in both the TLR3 pathway 
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stimulated by dsRNA and the TNFR1 pathways stimulated by TNFα (13). Using just 
TNFR1v1 knockdown simultaneously with the Traf2 tri-morphants did not rescue the 
mortality. There were still off-target morpholino effects, which could be because of the 
effects of the other TNFR1 gene still present.  
In mammalian systems, Traf2 has been shown to function as an E3 ligase that 
K63 poly-ubiquitinates cIAP-1/cIAP-2 and other proteins (34, 49). We looked at the 
potential for each of the three Traf2 paralogs to play a similar role with RIP1. Previous 
studies have shown that mammalian Traf2 function as an E3 ligase with Ubc13-Uev1a as 
the E2 ligase to polyubiquitinate RIP1 at K63 on RIP1 (4). When RIP1 is 
polyubiquitinated the tail of ubiquitin acts as a scaffold for other signaling molecules and 
complex formation (16). Alvarez et al found that sphingosine-1-phosphate is necessary 
for this reaction to take place (4). In our own transfection, we did used sphingosine-1-
phosphate and RIP1 as our potential target for ubiquitination. We did not however, see 
ubiquitination of RIP1 (Figures 20, 21). Traf2a2 and RIP1 were strongly expressed in the 
cells (Figures 20, 22). The other proteins may not have been expressed in the cells. To 
determine if Traf2a1 and Traf2b are viable for expression in the cells, sequencing would 
need to be done. In Figure 22 we do see the characteristic smearing of ubiquitin, but 
because both ubiquitin and Traf2 have the same HA tag we cannot definitively say 
Traf2a1, Traf2a2, and Traf2b are being masked by ubiquitination of something else in the 
cell. The three Traf2 paralogs were transfected separately and this could be part of the 
reason ubiquitination did not occur. Previous studies show that Traf2 oligomerizes with 
itself and other members of the Traf superfamily utilizing the Traf domain (7). Perhaps 
the existence of three Traf2 proteins in zebrafish means that for fully functional ability at 
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least two of the paralogs must be present to complex together, or for all three even to be 
necessary. Based on our own mortality studies earlier, where we saw a decrease in 
survival when two or more Traf2 paralogs were knocked down as opposed to the single 
Traf2 paralog morphants whose survival was not significantly different than control fish, 
it could be surmised that just two are necessary. With what we have seen so far, it is 
inconclusive whether the Traf2 paralogs are acting as E3 ubiquitin ligases for RIP1. 
Further experiments are necessary to determine if the zebrafish Traf2 paralogs act 
as ubiquitin ligases. In particular, I would try a transfection with all three paralogs in one 
set of cells with RIP1. Other transfections with potential targets for ubiquitination such as 
TAK1 would show if Traf2 in zebrafish is just targeting something else. The conditions 
of the transfection could also be modified. For instance, it would be beneficial to change 
the HA tag on ubiquitin to something else. With the current tag, our immunoprecipitate 
for HA may have become too saturated with ubiquitinated molecules to hold any of the 
Traf2 proteins. It would also be interesting to try another rescue of the phenotype seen in 
the Traf2 tri-morphants. This might be achieved by knocking down a different potential 
receptor, such as TLR 3 or TLR 9 and infecting the fish. Part of our difficulties in the 
experiments has been getting the fish to survive long enough to have a sufficient number 
for experiments at an older age. Co-injecting with the p53 morpholino as suggested by 
Bill et al could help to eliminate some of these off target effects (10).
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